Cargando…

Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners

INTRODUCTION: Amyotrophic lateral sclerosis (ALS), usually fatal in a few years, is a neurodegenerative disorder where the diagnostic delay, although variable according to the studies, remains too long. The main objective of this study was to determine the average time to diagnose ALS and the role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Matharan, Martin, Mathis, Stéphane, Bonabaud, Sarah, Carla, Louis, Soulages, Antoine, Le Masson, Gwendal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238340/
https://www.ncbi.nlm.nih.gov/pubmed/32455015
http://dx.doi.org/10.1155/2020/1473981
_version_ 1783536520994488320
author Matharan, Martin
Mathis, Stéphane
Bonabaud, Sarah
Carla, Louis
Soulages, Antoine
Le Masson, Gwendal
author_facet Matharan, Martin
Mathis, Stéphane
Bonabaud, Sarah
Carla, Louis
Soulages, Antoine
Le Masson, Gwendal
author_sort Matharan, Martin
collection PubMed
description INTRODUCTION: Amyotrophic lateral sclerosis (ALS), usually fatal in a few years, is a neurodegenerative disorder where the diagnostic delay, although variable according to the studies, remains too long. The main objective of this study was to determine the average time to diagnose ALS and the role of each physician, general practitioner (GP), or specialist (neurologist or not) involved in the management of these patients. The secondary objective was to propose some simple schemes to quickly identify an ALS suspicion with the aim to reduce this delay. Patients and Methods. This retrospective study evaluated the diagnostic delay (and other intermediate delays) of 90 ALS patients registered in the ALS Center of Bordeaux (France) in 2013. The main clinical signs encountered (and their order of appearance) were studied. RESULTS: The average diagnostic delay was 17 months, with a median diagnostic delay of 12 months. The average diagnostic delay was 2.7 months between the first symptoms and the first complaint to GP, followed by an additional 6.5 month delay before the patient's first visit to a neurologist. This period could be shortened, especially if GP performed additional tests quickly (p=0.01), as the time spent consulting various specialists often extends this crucial step. Overall, diagnostic delay accounted for 40% of the total duration of the disease progression. CONCLUSION: In relation to total survival time, the diagnostic delay of ALS appears to be proportionately very long, sometimes longer than that observed in previous studies (because it also included the total delay to diagnostic or treatment initiation). The rapid execution of useful additional tests by the first medical doctor, often GP (with the help of a neurologist), considerably reduces the diagnostic delay. The central role of GP seems to be crucial in the management of patients with ALS. The main objective is, of course, to initiate appropriate treatment and care as soon as possible. Finally, based on our results, we also provide a short practical diagram to help nonneurologist practitioners to quickly discuss the diagnosis of ALS in case of some specific symptoms (“red flags”).
format Online
Article
Text
id pubmed-7238340
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72383402020-05-22 Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners Matharan, Martin Mathis, Stéphane Bonabaud, Sarah Carla, Louis Soulages, Antoine Le Masson, Gwendal Neurol Res Int Research Article INTRODUCTION: Amyotrophic lateral sclerosis (ALS), usually fatal in a few years, is a neurodegenerative disorder where the diagnostic delay, although variable according to the studies, remains too long. The main objective of this study was to determine the average time to diagnose ALS and the role of each physician, general practitioner (GP), or specialist (neurologist or not) involved in the management of these patients. The secondary objective was to propose some simple schemes to quickly identify an ALS suspicion with the aim to reduce this delay. Patients and Methods. This retrospective study evaluated the diagnostic delay (and other intermediate delays) of 90 ALS patients registered in the ALS Center of Bordeaux (France) in 2013. The main clinical signs encountered (and their order of appearance) were studied. RESULTS: The average diagnostic delay was 17 months, with a median diagnostic delay of 12 months. The average diagnostic delay was 2.7 months between the first symptoms and the first complaint to GP, followed by an additional 6.5 month delay before the patient's first visit to a neurologist. This period could be shortened, especially if GP performed additional tests quickly (p=0.01), as the time spent consulting various specialists often extends this crucial step. Overall, diagnostic delay accounted for 40% of the total duration of the disease progression. CONCLUSION: In relation to total survival time, the diagnostic delay of ALS appears to be proportionately very long, sometimes longer than that observed in previous studies (because it also included the total delay to diagnostic or treatment initiation). The rapid execution of useful additional tests by the first medical doctor, often GP (with the help of a neurologist), considerably reduces the diagnostic delay. The central role of GP seems to be crucial in the management of patients with ALS. The main objective is, of course, to initiate appropriate treatment and care as soon as possible. Finally, based on our results, we also provide a short practical diagram to help nonneurologist practitioners to quickly discuss the diagnosis of ALS in case of some specific symptoms (“red flags”). Hindawi 2020-05-11 /pmc/articles/PMC7238340/ /pubmed/32455015 http://dx.doi.org/10.1155/2020/1473981 Text en Copyright © 2020 Martin Matharan et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Matharan, Martin
Mathis, Stéphane
Bonabaud, Sarah
Carla, Louis
Soulages, Antoine
Le Masson, Gwendal
Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners
title Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners
title_full Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners
title_fullStr Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners
title_full_unstemmed Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners
title_short Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners
title_sort minimizing the diagnostic delay in amyotrophic lateral sclerosis: the role of nonneurologist practitioners
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238340/
https://www.ncbi.nlm.nih.gov/pubmed/32455015
http://dx.doi.org/10.1155/2020/1473981
work_keys_str_mv AT matharanmartin minimizingthediagnosticdelayinamyotrophiclateralsclerosistheroleofnonneurologistpractitioners
AT mathisstephane minimizingthediagnosticdelayinamyotrophiclateralsclerosistheroleofnonneurologistpractitioners
AT bonabaudsarah minimizingthediagnosticdelayinamyotrophiclateralsclerosistheroleofnonneurologistpractitioners
AT carlalouis minimizingthediagnosticdelayinamyotrophiclateralsclerosistheroleofnonneurologistpractitioners
AT soulagesantoine minimizingthediagnosticdelayinamyotrophiclateralsclerosistheroleofnonneurologistpractitioners
AT lemassongwendal minimizingthediagnosticdelayinamyotrophiclateralsclerosistheroleofnonneurologistpractitioners